# Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.

> **NCT05520086** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz** · enrollment: 20 (actual)

## Conditions studied

- Chronic Conjunctivitis
- Stevens-Johnson Syndrome
- Lyell Syndrome
- Pemphigoid

## Interventions

- **DRUG:** Single Dose
- **DRUG:** Double Dose

## Key facts

- **NCT ID:** NCT05520086
- **Lead sponsor:** Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-11
- **Primary completion:** 2024-06-11
- **Final completion:** 2024-11-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05520086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05520086, "Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05520086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*